AstraZeneca initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Sarita Kapila initiated coverage of AstraZeneca (AZN) with an Overweight rating and 14,500 GBp price target The firm ...
BofA maintains Buy on AstraZeneca stock, GBP145.00 target
BofA Securities reiterated its Buy rating on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), with a steady price target of GBP145.00. The firm's positive stance is based on the pharmaceutical giant's ...
Prioritizing vaccine boosters for vulnerable patients could prevent emergence of new COVID variants
Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine ...
Morgan Stanley sets AstraZeneca stock Overweight with £145 target
AstraZeneca PLC (LON:AZN:LN) (NASDAQ: AZN), a pharmaceutical giant with a market capitalization of $224.5 billion, received a new Overweight rating from Morgan Stanley (NYSE:MS), accompanied by a ...